Considerations Around Structure-Based Drug Discovery for KRAS Using DOCK

Methods Mol Biol. 2024:2797:67-90. doi: 10.1007/978-1-0716-3822-4_6.

Abstract

Molecular docking is a popular computational tool in drug discovery. Leveraging structural information, docking software predicts binding poses of small molecules to cavities on the surfaces of proteins. Virtual screening for ligand discovery is a useful application of docking software. In this chapter, using the enigmatic KRAS protein as an example system, we endeavor to teach the reader about best practices for performing molecular docking with UCSF DOCK. We discuss methods for virtual screening and docking molecules on KRAS. We present the following six points to optimize our docking setup for prosecuting a virtual screen: protein structure choice, pocket selection, optimization of the scoring function, modification of sampling spheres and sampling procedures, choosing an appropriate portion of chemical space to dock, and the choice of which top scoring molecules to pick for purchase.

Keywords: Computational drug discovery; DOCK; Druggable pockets; Molecular docking; Virtual screening.

MeSH terms

  • Algorithms*
  • Binding Sites
  • Drug Discovery
  • Ligands
  • Molecular Docking Simulation
  • Protein Binding
  • Proteins / chemistry
  • Proto-Oncogene Proteins p21(ras)* / genetics
  • Proto-Oncogene Proteins p21(ras)* / metabolism
  • Software

Substances

  • Proto-Oncogene Proteins p21(ras)
  • Proteins
  • Ligands